Project Grant R01AI075452

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Rector & Visitors of the University of Virginia (UVA) to develop a vaccine against cryptosporidiosis, a common diarrheal disease that causes significant morbidity and mortality in sub-Saharan Africa and Asia, particularly among young children. The $242,250 grant, awarded on April 25, 2025, supports research to optimize...

This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $183,541 over 5 years to support an investigation of within-household transmission of influenza in low-resource settings. The research, led by a principal investigator at Yale University, aims to quantify influenza spread within households and develop a model to evaluate the effectiveness of interventions like...

This $375,000 federal Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) aims to evaluate the impact of a status-neutral, person-centric intervention called the "Blue Shed" on HIV transmission and outcomes among people who inject drugs (PWID) in New Delhi, India. The project has three key objectives: Assess the direct impact of the Blue Shed intervention on HIV incidence, viral suppression, and mortality among PWID...

This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support research to model the impact of water, sanitation, and hygiene (WASH) interventions on reducing transmission of typhoidal Salmonella in the Indo-Pacific region. The $169,035 award, with a start date of September 11, 2024 and an ultimate completion date of August 31, 2029, will utilize data from the Revitalizing...

The National Science Foundation (NSF) awarded a $100,000 Project Grant under the Social, Behavioral, and Economic Sciences program (CFDA 47.075) to Trustees of Boston University. The grant will fund a 2-year research project to improve the estimation of epidemic quantities and assessment of intervention impacts for acute infectious diseases by incorporating realistic behavioral feedback into mechanistic models. The project involves recruiting individuals with acute respiratory infections...

This Project Grant award for $147,656 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to uncover the three-dimensional ultrastructure, molecular architecture, and composition of the host-parasite interface of the Cryptosporidium pathogen. The research aims to reveal mechanisms of membrane remodeling and nutrient acquisition fundamental to intracellular parasitism, with the goal of...

This Project Grant award from the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) provides $560,000 to Baylor College of Medicine to explore the use of wastewater surveillance for detecting HIV and tuberculosis (TB) in Eswatini. The key objectives are to: 1) Establish a pipeline for wastewater surveillance of HIV and TB in Eswatini, building on the institution's prior experience; 2) Validate and quantify the...

This Project Grant award from the Fogarty International Center (CFDA 93.989 - International Research and Research Training) provides $1,000,000.00 to the University of Illinois to study pathogen transmission dynamics between wildlife and human settlements in rural western Uganda. The key objectives are to: 1) conduct longitudinal surveillance of adenovirus in wild non-human primates, domestic animals, insects, and environmental samples; 2) apply advanced phylogenetic and bioinformatics methods...

This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $142,932 to The Trustees of Columbia University in the City of New York to investigate the use of wastewater surveillance data to improve forecasting of SARS-CoV-2 transmission dynamics. The project aims to evaluate whether incorporating wastewater data can enhance the accuracy of predictive models for COVID-19 cases...

This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) provides $382,852 to Brown University to develop methodological innovations for improving the use of observational causal inference models to estimate the population-level impact of interventions on infectious disease outcomes. The key products and services to be delivered include: Proposing robust specifications for observational...